{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T12:26:12Z","timestamp":1768739172041,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,4,9]],"date-time":"2014-04-09T00:00:00Z","timestamp":1397001600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s10792-014-9938-4","type":"journal-article","created":{"date-parts":[[2014,4,8]],"date-time":"2014-04-08T21:12:45Z","timestamp":1396991565000},"page":"221-227","source":"Crossref","is-referenced-by-count":34,"title":["Subconjunctival and\/or intrastromal bevacizumab injections as preconditioning therapy to promote corneal graft survival"],"prefix":"10.1007","volume":"35","author":[{"given":"Romina","family":"Fasciani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Mosca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Ilaria","family":"Giannico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone Antonio","family":"Ambrogio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"Balestrazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,9]]},"reference":[{"issue":"5","key":"9938_CR1","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.survophthal.2012.01.007","volume":"57","author":"Jin-Hong Chang","year":"2012","unstructured":"Chang Jin-Hong, Garg Nitin K, Lunde Elisa et al (2012) Corneal neovascularization: an anti-VEGF therapy review. Surv Ophtahalmol 57(5):415\u2013429","journal-title":"Surv Ophtahalmol"},{"key":"9938_CR2","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/j.jcrs.2007.07.012","volume":"33","author":"A Awadein","year":"2007","unstructured":"Awadein A (2007) Subconjunctival bevacizumab for vascularized rejected corneal grafts. J Cataract Refract Surg 33:1991\u20131993","journal-title":"J Cataract Refract Surg"},{"issue":"7","key":"9938_CR3","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/ICO.0b013e3182014668","volume":"30","author":"HY Patel","year":"2011","unstructured":"Patel HY, Ormonde S, Brookes NH et al (2011) The New Zeland National Eye Bank: survival and visual outcome 1\u00a0year after penetrating keratoplasty. Cornea 30(7):760\u2013764","journal-title":"Cornea"},{"issue":"4","key":"9938_CR4","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.survophthal.2007.04.008","volume":"52","author":"A Panda","year":"2007","unstructured":"Panda A, Vanathi M, Kumar A, Dash Y, Priya S (2007) Corneal graft rejection. Surv Ophthalmol 52(4):375\u2013396","journal-title":"Surv Ophthalmol"},{"key":"9938_CR5","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s00417-009-1170-y","volume":"247","author":"PI Vassileva","year":"2009","unstructured":"Vassileva PI, Hergeldzhieva TG (2009) Avastin use in high risk corneal transplantation. Graefes Arch Clin Exp Ophthalmol 247:1701\u20131706","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"9938_CR6","first-page":"18","volume":"39","author":"S Amano","year":"1998","unstructured":"Amano S, Rohan R, Kuroki M et al (1998) Requirement for vascular endothelial growth factor in wound and inflammation related corneal neovascularization. Invest Ophthalmol Vis Sci 39:18\u201322","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9938_CR7","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1080\/02713680701767884","volume":"32","author":"JY Niederkorn","year":"2007","unstructured":"Niederkorn JY (2007) Immune mechanisms of corneal allograft rejection. Curr Eye Res 32:1005\u20131016","journal-title":"Curr Eye Res"},{"key":"9938_CR8","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1755-3768.2009.01596.x","volume":"87","author":"U Pleyer","year":"2009","unstructured":"Pleyer U, Schlickeiser S (2009) The taming of the shrew? The immunology of corneal transplantation. Acta Ophthalmol 87:488\u2013497","journal-title":"Acta Ophthalmol"},{"issue":"8","key":"9938_CR9","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1097\/ICO.0b013e3182012a1a","volume":"30","author":"L Mosca","year":"2011","unstructured":"Mosca L, Fasciani R, Mosca L et al (2011) Graft rejection after Femtosecond-assisted deep anterior lamellar keratoplasty: report of 3 cases. Cornea 30(8):912\u2013916","journal-title":"Cornea"},{"key":"9938_CR10","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ajo.2010.01.042","volume":"150","author":"G Alessio","year":"2010","unstructured":"Alessio G, L\u2019Abbate M, Boscia F et al (2010) Excimer laser-assisted keratoplasty and the corneal endothelium. Am J Ophthalmol 150:88\u201396","journal-title":"Am J Ophthalmol"},{"key":"9938_CR11","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1007\/s004170050387","volume":"237","author":"AM Joussen","year":"1999","unstructured":"Joussen AM, Kruse FE, Volcker HE et al (1999) Topical application of methotrexate for inhibition of corneal angiogenesis. Graefes Arch Clin Exp Ophthalmol 237:920\u2013927","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"9938_CR12","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/archopht.1992.01080150103037","volume":"110","author":"RM Lipman","year":"1992","unstructured":"Lipman RM, Epstein RJ, Hendricks RL (1992) Suppression of corneal neovascularization with cyclosporine. Arch Ophthalmol 110:405\u2013407","journal-title":"Arch Ophthalmol"},{"key":"9938_CR13","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1073\/pnas.91.9.4082","volume":"91","author":"RJ D\u2019Amato","year":"1994","unstructured":"D\u2019Amato RJ, Loughnan MS, Flynn E et al (1994) Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA 91:4082\u20134085","journal-title":"Proc Natl Acad Sci USA"},{"key":"9938_CR14","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1006\/exer.1999.0790","volume":"70","author":"A Kvanta","year":"2000","unstructured":"Kvanta A, Sarman S, Fagerholm P et al (2000) Expression of matrix metalloproteinase-2 (MMP-2) and vascular endothelial growth factor (VEGF) in inflammation associated corneal neovascularization. Exp Eye Res 70:419\u2013428","journal-title":"Exp Eye Res"},{"key":"9938_CR15","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1600-0420.2004.00312.x","volume":"82","author":"L Gan","year":"2004","unstructured":"Gan L, Fagerholm P, Palmblad J (2004) Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in the regulation of corneal neovascularization and wound healing. Acta Ophthalmol Scand 82:557\u2013563","journal-title":"Acta Ophthalmol Scand"},{"key":"9938_CR16","first-page":"1112","volume":"40","author":"JL Edelman","year":"1999","unstructured":"Edelman JL, Castro MR, Wen Y (1999) Correlation of VEGF expression by leukocytes with the growth and regression of blood vessels in the rat cornea. Invest Ophthalmol Vis Sci 40:1112\u20131123","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"9938_CR17","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/ICO.0b013e31823f8d71","volume":"31","author":"Y Benayoun","year":"2012","unstructured":"Benayoun Y, Adenis JP, Casse G et al (2012) Effects of subconjunctival bevacizumab on corneal neovascularization: results of a prospective study. Cornea 31(8):934\u2013944","journal-title":"Cornea"},{"key":"9938_CR18","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/ICO.0b013e3181ba0ae2","volume":"29","author":"RJ Symes","year":"2010","unstructured":"Symes RJ, Poole TRG (2010) Corneal graft surgery combined with subconjunctival bevacizumab (Avastin). Cornea 29:691\u2013693","journal-title":"Cornea"},{"issue":"5","key":"9938_CR19","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s10792-013-9732-8","volume":"33","author":"BT Acar","year":"2013","unstructured":"Acar BT, Halili E, Acar S (2013) The effect of different doses of subconjunctival bevacizumab injection on corneal neovascularization. Int Ophthalmol 33(5):507\u2013513","journal-title":"Int Ophthalmol"},{"key":"9938_CR20","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/bjophthalmol-2012-302137","volume":"97","author":"C Petsoglou","year":"2013","unstructured":"Petsoglou C, Balaggan KS, Dart JKG et al (2013) Subconjunctival bevacizumab induces regression of corneal neovascularisation: a pilot randomized placebo-controlled double-masked trial. Br J Ophthalmol 97:28\u201332","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"9938_CR21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jtos.2012.01.005","volume":"10","author":"W Stevenson","year":"2012","unstructured":"Stevenson W, Cheng SF, Dastjerdi MH et al (2012) Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin). Ocul Surf 10(2):67\u201383","journal-title":"Ocul Surf"},{"key":"9938_CR22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/978-1-4612-3146-2_3","volume-title":"Neuroendocrine Perspectives","author":"N Ferrara","year":"1991","unstructured":"Ferrara N, Leung DW, Phillips HS (1991) Molecular characterization and distribution of vascular endothelial growth factor. In: Muller EE, MacLeod RB (eds) Neuroendocrine Perspectives. Springer-Verlag, New York, p 127"},{"key":"9938_CR23","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1242\/dev.114.2.521","volume":"114","author":"G Breier","year":"1992","unstructured":"Breier G, Albrecht U, Sterrer S et al (1992) Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 114:521\u2013532","journal-title":"Development"},{"issue":"5","key":"9938_CR24","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1167\/iovs.09-3745","volume":"51","author":"NH Dastjerdi","year":"2010","unstructured":"Dastjerdi NH, Saban DN, Okanobo A et al (2010) Effects of topical and subconjunctival bevacizumab in high-risk corneal transplant survival. Invest Ophthalmol Vis Sci 51(5):2411\u20132417","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9938_CR25","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/ICO.0b013e3180318107","volume":"26","author":"LR Niederer","year":"2007","unstructured":"Niederer LR, Sherwin T, McGhee CNJ (2007) In vivo confocal microscopy of subepithelial infiltrates in human corneal transplant rejection. Cornea 26:501\u2013504","journal-title":"Cornea"},{"key":"9938_CR26","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1172\/JCI20465","volume":"113","author":"C Cursiefen","year":"2004","unstructured":"Cursiefen C, Chen Lu, Borges LP et al (2004) VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophages recruitment. J Clin Invest 113:1040\u20131050","journal-title":"J Clin Invest"},{"key":"9938_CR27","unstructured":"Traversi C, Nuti E, Bovone C (2009) Principi di immunologia. Newsletter S.I.TRA.C. No 3, 1\u20132 Oct 2009"},{"key":"9938_CR28","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/00003226-199811000-00008","volume":"17","author":"C Cursiefen","year":"1998","unstructured":"Cursiefen C, K\u00fcchle M (1998) Naumann GOH: angiogenesis in corneal diseases: histopathologic evaluation of 254 human corneal buttons with neovascularisation. Cornea 17:611\u2013613","journal-title":"Cornea"},{"key":"9938_CR29","unstructured":"Rama P, Insacco C (2009). Rigetto nel trapianto di cornea perforante. Newsletter S.I.TRA.C.No 3, 3\u20134 Oct 2009"},{"key":"9938_CR30","unstructured":"Fontana L, Parente G, Tassinari G (2009). Reazioni di rigetto dopo cheratoplastica lamellare anteriore profonda, aspetti clinici. Newsletter S.I.TRA.C.No 3, 3 Oct 2009"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-014-9938-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10792-014-9938-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-014-9938-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T03:42:18Z","timestamp":1648784538000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10792-014-9938-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,9]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["9938"],"URL":"https:\/\/doi.org\/10.1007\/s10792-014-9938-4","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,9]]}}}